# Catheter Precision (VTAK) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/VTAK
## Company Profile
- Ticker: VTAK
- Exchange: NYSE
- Sector: MedTech
- Location: United States
- Tags: MedTech
## Stock Data
- Close: 0.21 USD
- Market cap: 2584774.08 USD
- Last updated: 2026-09-04
## Business Overview
Catheter Precision is a medical technology company focused on electrophysiology and catheter-based tools used in cardiac procedures. Its business is centered on procedural guidance rather than drug development.
## Why The Stock Is Moving

As of Sep 4, 2026, VTAK closed up 6.82% at $0.2100. No new same-company headline was identified in the current news window.

## Geographic Base

Catheter Precision is headquartered in the United States and listed on NASDAQ. It sits in cardiac-device medtech rather than biotechnology.

## Business Model

The company depends on device adoption, physician training, and regulatory or commercial milestones in electrophysiology labs. Investors watch product uptake, procedure placement, and operating execution.

## Landscape Position

Catheter Precision occupies a cardiac-device niche within healthcare innovation. It is not biotech, but it belongs in the procedural-medtech layer where clinical adoption drives value.

## Future Catalysts

- Catheter Precision’s catalysts are EP-device adoption, procedural workflow growth, and any strategic update that clarifies the company’s commercialization path. The market will care about whether the platform can keep winning procedure share.

## Recent News
- 2026-09-02 20:15 EST — [Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean](https://biopharmsignal.com/news/VTAK/flyte-secures-international-approval-to-launch-private-aviation-service-across-t-0f1936b8) — Source: Catheter Precision
- 2026-08-27 12:00 EST — [Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany](https://biopharmsignal.com/news/VTAK/catheter-precision-achieves-major-commercial-milestones-with-cardinal-health-joh-14fd9a80) — Source: Catheter Precision
- 2026-08-20 11:30 EST — [Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates](https://biopharmsignal.com/news/VTAK/flyte-surpasses-10-000-consumer-accounts-as-webapp-growth-accelerates-4057d261) — Source: Catheter Precision
- 2026-08-18 20:15 EST — [Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market](https://biopharmsignal.com/news/VTAK/flyte-partners-with-fullpac-to-bring-regional-aviation-to-the-11-4-billion-u-s-p-c6410877) — Source: Catheter Precision
- 2026-08-11 12:15 EST — [Flyte Partners with The Nucleus Network for Inaugural Flagship Founder & Investor Event](https://biopharmsignal.com/news/VTAK/flyte-partners-with-the-nucleus-network-for-inaugural-flagship-founder-investor--f677b5a0) — Source: Catheter Precision